{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-24-002229","form_type":"8-K","ticker":"BGLC","cik":"0001737523","company_name":"BioNexus Gene Lab Corp","filed_at":"2024-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.819735+00:00","generated_at":"2026-06-03T19:09:48.354688+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"BioNexus Gene Lab invests RM1.2M for 10% stake in Malaysian digital health firm AISB","bullets":["Investment of RM1.2M (~$250k) via subsidiary MRNA Scientific for ~10% equity in Ascension Innovation (AISB).","Funding to accelerate AISB's AI platform aiCMS with predictive analytics, AI diagnosis aids, and more.","AISB projects revenue of RM75M collectively for 2024-2028; currently 145k+ users and 30+ providers.","Investment supports BGLC's genomic diagnostics integration into AISB's platform to expand market reach."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-24-002229","json":"https://secwatch.observer/filing/0001477932-24-002229.json","markdown":"https://secwatch.observer/filing/0001477932-24-002229.md","text":"https://secwatch.observer/filing/0001477932-24-002229.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737523/000147793224002229/0001477932-24-002229-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737523/000147793224002229/bglc_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T19:09:48.354688+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}